OV038-Deep-Tech-email-header2

issue #8

Hello World,

Simon here, writing from lockdown. You’ve got to enjoy the little things at times like these and for me, it is sitting here at a cluttered, disordered desk. There’s papers, journal articles, books, old coffee mugs, moisturiser, decks of cards and pens scattered around. I love it and thrive in chaos. But the best bit... no-one is going to hot-desk here after me so at the end of the day I can get up and just walk away 😊. Bliss.

On the team, I’m the one who has been going down coronavirus research rabbit holes 🤓🐰 and now is the most important time to pay attention! Why? Because it is only now that we have had sufficient time and patients to study for the meaty work to get done! As one example, this comment piece in the Lancet from Feb 2020 provided good (historic), clinical evidence why corticosteroids were unlikely to be effective as a treatment for covid-19. Fast forward to June and dexamethasone (a cheap corticosteroid) has been shown to reduce deaths in certain patients. While we’re all hoping for a one-stop cure-all, lots of small steps forward might get us to a good place faster!

But how to stay on-top of all the work being done? I’m using Johns Hopkins coronavirus resource center for data, MedCram’s free videos (also on YouTube) for rapid expert assessment of research, UpToDate for peer reviewed literature used by clinicians and RAPS to track vaccine progress. Let me know if you’ve found other good resources (simon.king@octopusventures.com).

A massive shout out and congratulations to the amazing folk at deep tech portfolio company UltraSoC who were acquired last month by Siemens Mentor. UltraSoC has built some fantastic technology to keep track of what is happening on a System-on-a-Chip (SoC) at a hardware level. Gajinder Panesar, UltraSoC’s CTO, explains more about the applications of the technology here. And our very own Dr. Luke Hakes has voiced his personal experience of sitting on the board at UltraSoC here.

Finally, much love for Zoe Chambers from our Deep Tech pod, as she talks to New Scientist about how entrepreneurs with the right drive and some capital behind them can go after the big crazy ideas.

gray-line - a

Since our last issue, we've been:

  • Contemplating buying a dog for company in lockdown from Boston Robotics 🐶 🤖. 
  • Blown away by planning approval for the first vertical rocket launch site in the UK!
  • Having mixed feelings about Huawei building a massive research centre in Cambridge… great for the ecosystem, but talent is about to get even more expensive!
  • Reading these stats on online behavior in the UK 2019-2020 and what has changed during lockdown.
  • Intrigued to see Wandelbots get funding, given we have long held the belief that easy programming of robots will drive wider adoption in manufacturing facilities. We will watch closely!
  • Unsurprised that powerful quantum claims continue to be challenged by divided commentators.
  • Watching some interesting mobility and mapping acquisitions such as Moovit (Intel’s Mobileye), Mapillary (Facebook) and Zoox (Amazon).
  • Very excited by Apple’s range of announcements on ARKit 4. Next stop, an interactive digital twin of reality, created by your iPhone!
  • Following developments in synthesising datasets to augment real-world data and build computer vision models – we are very familiar with data acquisition issues within our own companies so we suspect this could really accelerate the pipeline.
gray-line - a

Please don't forget we love hearing from you on anything included here, anything else deep tech-related, SciFi books you’re reading or any other topic we can geek-out to! And do of course share the newsletter if you know others we should be connecting with. If you're just visiting, then you can sign up to receive our next issue here

Stay sane and healthy!
Love to you all,
Simon

gray-line - a